Profile: NexBio, Inc. is a biotechnology company that develops a broad-spectrum of biopharmaceuticals to prevent & treat current and emerging life-threatening human disease. Our Fludase® is a novel broad-spectrum recombinant protein for the prophylaxis and treatment of Influenza-like illness caused by all influenza & parainfluenza viruses, as well as pandemic influenza caused by strains such as H5N1. We offer Viradin™ intravenous therapeutic for sepsis and septic shock as well as viral hemorrhagic fever caused by pathogens such as ebola & marburg viruses.